R12020 |
INCB057643 |
INCB-057643 is a novel, orally bioavailable BET inhibitor.
|
R12021 |
MIK665 |
N/A
|
R12022 |
GTS-21 |
N/A
|
R12023 |
MMAD (Synonyms: Demethyldolastatin 10; Monomethylauristatin D; Monomethyl Dolastatin 10) |
MMAD is a potent tubulin inhibitor, is a toxin payload in antibody drug conjugat
|
R12024 |
VcMMAE (Synonyms: mc-vc-PAB-MMAE) |
VcMMAE (mc-vc-PAB-MMAE) is a drug-linker conjugate for ADC with potent antitumor
|
R12025 |
MMAF (Synonyms: Monomethylauristatin F) |
MMAF (Monomethylauristatin F) is a potent tubulin polymerization inhibitor and i
|
R12026 |
Mc-MMAE (Synonyms: Maleimidocaproyl-monomethylauristatin E) |
Mc-MMAE is a protective group (maleimidocaproyl)-conjugated monomethyl auristati
|
R12027 |
Mc-Val-Cit-PABC-PNP |
Mc-Val-Cit-PABC-PNP is a cathepsin cleavable ADC linker used in the sy
|
R12028 |
SMCC-DM1 (Synonyms: DM1-SMCC) |
SMCC-DM1 (DM1-SMCC) is a drug-linker conjugate composed of a potent microtubule-
|
R12029 |
Fmoc-Val-Cit-PAB |
Fmoc-Val-Cit-PAB is a cleavable linker for antibody-drug-conjugation (ADC). 
|
R12030 |
Fmoc-val-cit-pab-pnp |
Fmoc-Val-Cit-PAB-PNP is a cleavable peptide linker, is a linker for antibody-dru
|
R12031 |
Val-Cit-PAB |
Val-cit-PAB-OH is a cleavable ADC linker.
|
R12032 |
Auristatin E |
Auristatin E is a cytotoxic tubulin modifier with potent and selective antitumor
|
R12033 |
NDMM |
N/A
|
R12035 |
CGP 52432 |
N/A
|
R12001 |
4-AMINO-3-FURAZANECARBOXAMIDOXIME |
N/A
|
R181129 |
NBD-Glucose |
2-NBDG is a fluorescent indicator for direct glucose uptake measurement and also
|
R181130 |
SB225002 |
SB225002, a potent, selective and non-peptide CXCR2 antagonist, inhibits 125I-IL
|
R181131 |
Cutamesine dihydrochloride (Synonyms: SA4503 dihydrochloride; AGY94806 dihydrochloride) |
Cutamesine dihydrochloride (SA4503 dihydrochloride; AGY94806 dihydrochloride) is
|
R181132 |
Cutamesine (SA4503; AGY-94806) |
Cutamesine (SA4503; AGY-94806) is a selective sigma 1 receptor(σ1R) agonist; hig
|
R181133 |
Golvatinib (E7050) |
Golvatinib (E-7050) is a potent dual inhibitor of both c-Met and VEGFR2 kinases
|
R181134 |
GI254023X (Synonyms: GI4023; SRI028594) |
GI254023X is a potent MMP9 and ADAM10 inhibitor with IC50s of 2.5 and 5.3 nM, re
|
R181135 |
CUDC101 |
CUDC-101 is a potent inhibitor of HDAC, EGFR, and HER2 with IC50s of 4.4, 2.4, a
|
R181137 |
O-304 |
O-304 is a first-in-class, orally available pan-AMPK activator, which increases
|
R181138 |
LAU159 |
LAU159 is a functionally selective positive modulator of α1β3 GABA(A) receptor w
|